A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid Tumors
Clinical trial NCT04623892 · UNKNOWN
Trial details
- NCT number
- NCT04623892
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2021-07-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.